SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 445.39 |
| Enterprise Value ($M) | 870.96 |
| Book Value ($M) | 258.53 |
| Book Value / Share | 12.71 |
| Price / Book | 1.72 |
| NCAV ($M) | -137.00 |
| NCAV / Share | -6.74 |
| Price / NCAV | -3.25 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.02 |
| Return on Assets (ROA) | 0.02 |
| Return on Equity (ROE) | 0.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.69 |
| Current Ratio | 3.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 570.77 |
| Assets | 966.29 |
| Liabilities | 707.76 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1,017.68 |
| Operating Income | 59.34 |
| Net Income | 2.42 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 87.59 |
| Cash from Investing | -48.19 |
| Cash from Financing | -6.77 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | BFI Co., LLC | 49.90 | 0.00 | |
| 13G/A | Brandes Investment Partners, Lp | 7.30 | -30.33 | |
| 13G/A | Vanguard Group Inc | 7.34 | 0.00 | |
| 13G | Pzena Investment Management Llc | |||
| 13G/A | BlackRock, Inc. | 18.00 | 0.12 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,907 | 64,699 | 24.59 | |
| 16,955 | 81,862 | 20.71 | |
| 38,328 | 158,935 | 24.12 | |
| 16,227 | 84,776 | 19.14 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OCS – Oculis Holding AG | OCUL – Ocular Therapeutix, Inc. |
| OMER – Omeros Corporation | PROC – Procaps Group S.A. |
| PTGX – Protagonist Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io